{"id":"https://openalex.org/W2578030596","doi":"https://doi.org/10.1182/blood.v124.21.173.173","title":"Synthetic Lethal Approaches to Exploit Replicative Stress in Aggressive Myeloma","display_name":"Synthetic Lethal Approaches to Exploit Replicative Stress in Aggressive Myeloma","publication_year":2014,"publication_date":"2014-12-06","ids":{"openalex":"https://openalex.org/W2578030596","doi":"https://doi.org/10.1182/blood.v124.21.173.173","mag":"2578030596"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v124.21.173.173","doi":"https://doi.org/10.1182/blood.v124.21.173.173","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v124.21.173.173","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034020009","display_name":"Francesca Cottini","orcid":"https://orcid.org/0000-0001-8676-7840","observed_orcids":["https://orcid.org/0000-0001-8676-7840"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Francesca Cottini","raw_affiliation_strings":["Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091207345","display_name":"Teru Hideshima","orcid":"https://orcid.org/0000-0003-2939-6224","observed_orcids":["https://orcid.org/0000-0003-2939-6224"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Teru Hideshima","raw_affiliation_strings":["Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039444594","display_name":"Rikio Suzuki","orcid":"https://orcid.org/0000-0002-2841-6230","observed_orcids":["https://orcid.org/0000-0002-2841-6230"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rikio Suzuki","raw_affiliation_strings":["Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043526996","display_name":"Paul Gerard Guy Richardson","orcid":"https://orcid.org/0000-0002-7426-8865","observed_orcids":["https://orcid.org/0000-0002-7426-8865"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul G. Richardson","raw_affiliation_strings":["Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032464400","display_name":"Kenneth Carl Anderson","orcid":"https://orcid.org/0000-0002-6418-0886","observed_orcids":["https://orcid.org/0000-0002-6418-0886"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth C. Anderson","raw_affiliation_strings":["Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5050323670","display_name":"Giovanni Tonon","orcid":"https://orcid.org/0000-0003-2973-5038","observed_orcids":["https://orcid.org/0000-0003-2973-5038"]},"institutions":[{"id":"https://openalex.org/I4210133214","display_name":"IRCCS Ospedale San Raffaele","ror":"https://ror.org/039zxt351","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210133214","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Giovanni Tonon","raw_affiliation_strings":["San Raffaele Scientific Institute, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"San Raffaele Scientific Institute, Milan, Italy","institution_ids":["https://openalex.org/I4210133214"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5050323670","https://openalex.org/A5091207345"],"corresponding_institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210133214"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.34598224,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"124","issue":"21","first_page":"173","last_page":"173"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9437999725341797,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9437999725341797,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.045899998396635056,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9890000224113464},{"id":"https://openalex.org/keywords/synthetic-lethality","display_name":"synthetic lethality","score":0.906000018119812},{"id":"https://openalex.org/keywords/replicative-stress","display_name":"replicative stress","score":0.9959999918937683},{"id":"https://openalex.org/keywords/atr-inhibition","display_name":"ATR inhibition","score":0.8240000009536743},{"id":"https://openalex.org/keywords/ve-821","display_name":"VE-821","score":0.9330000281333923},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.9459999799728394},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.8109999895095825},{"id":"https://openalex.org/keywords/chromosomal-instability","display_name":"chromosomal instability","score":0.6819999814033508},{"id":"https://openalex.org/keywords/stalled-replication-forks","display_name":"stalled replication forks","score":0.7459999918937683},{"id":"https://openalex.org/keywords/53bp1-foci","display_name":"53BP1 foci","score":0.7979999780654907},{"id":"https://openalex.org/keywords/rad51-foci","display_name":"RAD51 foci","score":0.8820000290870667},{"id":"https://openalex.org/keywords/rpa-foci","display_name":"RPA foci","score":0.699999988079071},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.382999986410141},{"id":"https://openalex.org/keywords/gene-expression-signatures","display_name":"gene expression signatures","score":0.5540000200271606},{"id":"https://openalex.org/keywords/prognosis","display_name":"prognosis","score":0.3109999895095825}],"concepts":[{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.7581350207328796},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6931134462356567},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.6114030480384827},{"id":"https://openalex.org/C178169997","wikidata":"https://www.wikidata.org/wiki/Q2892636","display_name":"Genome instability","level":4,"score":0.6018797159194946},{"id":"https://openalex.org/C73573662","wikidata":"https://www.wikidata.org/wiki/Q130996","display_name":"DNA replication","level":3,"score":0.5808139443397522},{"id":"https://openalex.org/C2779012473","wikidata":"https://www.wikidata.org/wiki/Q3235015","display_name":"RAD51","level":4,"score":0.543059229850769},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.46642833948135376},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.44657933712005615},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4303114712238312},{"id":"https://openalex.org/C134305767","wikidata":"https://www.wikidata.org/wiki/Q725508","display_name":"Somatic cell","level":3,"score":0.4253786504268646},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.3843839466571808},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.35415729880332947},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.3365301489830017}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v124.21.173.173","doi":"https://doi.org/10.1182/blood.v124.21.173.173","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v124.21.173.173","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1782106562","https://openalex.org/W2556879866","https://openalex.org/W2110579764","https://openalex.org/W2944281167","https://openalex.org/W4200013017","https://openalex.org/W879951825","https://openalex.org/W2987391075","https://openalex.org/W2616779595","https://openalex.org/W2606853780","https://openalex.org/W4385948980"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Multiple":[2],"myeloma":[3,178,273,513,556,580],"(MM)":[4],"cells":[5,31,228,239,445,528],"show":[6],"a":[7,73,148,161,171,195,206,261,291,323,340,461,571],"variable":[8],"combination":[9,550],"of":[10,34,60,91,123,163,175,220,245,248,267,288,298,339,342,349,368,373,383,402,433,458,485,497,506,520,573,619],"chromosomal":[11,155],"translocations,":[12],"copy-number":[13],"variations,":[14],"somatic":[15],"mutations":[16],"and":[17,63,94,106,112,118,130,157,218,281,296,358,414,439,509,526,538,559,583,599,607],"clonal":[18],"heterogeneity,":[19],"which":[20,37,68,236,336,422],"makes":[21],"every":[22],"patient":[23,562],"unique.":[24],"We":[25,145,223,501],"have":[26,32,87,577],"recently":[27],"shown":[28],"that":[29,202,226,463],"MM":[30,80,99,143,164,227,304,316,467,563,574,605],"signs":[33],"ongoing":[35],"DNA-damage,":[36],"activates":[38],"an":[39,190,246,389,417],"ATM/ABL1-dependent":[40],"DNA":[41,61,85,92,128,158,392,412,435,594,601],"damage":[42,62,86,159,595],"response":[43,329],"(DDR)":[44],"without":[45],"overt":[46],"apoptosis":[47],"(Cottini":[48],"et":[49],"al.,":[50],"Nat":[51],"Med,":[52],"2014).":[53],"Here":[54],"we":[55,255,452],"further":[56],"characterize":[57],"the":[58,70,183,210,243,265,347,366,381,399,455,482,494,504,518,549,590],"mechanisms":[59],"replicative":[64,124,135,216,233,350,440,508],"stress":[65,136,217,234,351,441,511,567],"in":[66,89,141,160,264,271,293,303,331,360,365,380,391,512,554,561,570],"MM,":[67,344,361],"provide":[69],"basis":[71],"for":[72,153],"novel":[74],"synthetic":[75],"lethality":[76],"treatment":[77,415,551],"approach.":[78],"Results:":[79],"cell":[81,95,100,211,274,294,305,317,334,378,468,557,581],"lines":[82,101,306,318,469,558],"with":[83,109,127,177,277,283,307,321,346,416,491,531,536,540,611],"active":[84,359],"enrichment":[88],"pathways":[90],"replication":[93,132,269],"cycle.":[96],"These":[97,199],"same":[98],"also":[102,139,146,188,387,410,560],"present":[103,140,205,569],"53BP1,":[104,116],"RPA":[105,117],"RAD51":[107,119],"foci":[108,120],"activated":[110],"ATR":[111,289,325,385,532],"CHK1.":[113],"Of":[114],"note,":[115],"are":[121,138,337,446],"markers":[122,137],"stress,":[125,451],"associated":[126],"hyper-replication":[129,369],"stalled":[131,268],"forks.":[133],"Importantly,":[134],"primary":[142],"cells.":[144,169,564],"demonstrated":[147],"gene":[149],"expression":[150],"signature":[151],"specific":[152,324,495],"increased":[154],"instability":[156,184],"cohort":[162],"patients":[165,176,204,610],"versus":[166],"normal":[167,278],"plasma":[168],"Remarkably,":[170],"subset":[172],"(20":[173],"percent)":[174],"overexpress":[179],"genes":[180],"belonging":[181],"to":[182,194,209,232,241,258,449,472,516,522,588,621],"signature;":[185],"this":[186,253],"group":[187,572],"shows":[189],"unfavorable":[191,613],"prognosis":[192],"due":[193],"more":[196,301],"aggressive":[197,343,578],"disease.":[198],"findings":[200],"suggest":[201],"some":[203],"similar":[207,311],"phenotype":[208,312],"lines,":[212,275,335],"characterized":[213],"by":[214,398,426,548,596],"extensive":[215],"activation":[219,372],"hyper-replicative":[221],"pathways.":[222],"therefore":[224],"hypothesized":[225],"might":[229],"be":[230],"sensitive":[231,448,471],"overload,":[235],"occurs":[237],"when":[238,315],"fail":[240],"endure":[242],"presence":[244],"excess":[247],"unrepaired":[249,523],"DNA.":[250,524],"To":[251],"evaluate":[252],"hypothesis,":[254],"used":[256],"shRNAs":[257,533],"silence":[259],"ATR,":[260],"protein":[262],"involved":[263],"control":[266],"origins,":[270],"two":[272],"one":[276],"TP53":[279,285,332,363],"(H929)":[280],"another":[282],"mutant":[284,308,333],"(OPM-2).":[286],"Inhibition":[287],"caused":[290],"reduction":[292],"growth":[295,606],"induction":[297],"apoptosis,":[299],"both":[300,555],"evident":[302,553],"TP53.":[309],"A":[310],"was":[313,430],"observed":[314],"were":[319,470,477,487,529,552],"incubated":[320,539],"VE-821,":[322],"inhibitor.":[326],"The":[327],"strongest":[328],"occurred":[330],"representative":[338],"model":[341],"consistent":[345],"concept":[348],"overload.":[352],"Indeed,":[353],"p53":[354],"is":[355,568],"normally":[356],"phosphorylated":[357],"while":[362,475],"loss":[364],"context":[367],"may":[370,608],"prevent":[371],"salvage":[374],"checkpoint,":[375],"thereby":[376],"favoring":[377],"death":[379],"absence":[382],"ATR.":[384],"inhibition":[386],"induces":[388,464],"increase":[390],"double":[393,436],"strand":[394,437],"breaks,":[395],"as":[396],"evidenced":[397],"higher":[400],"number":[401],"\u03b3-H2A.X":[403],"foci.":[404],"Reactive":[405],"oxygen":[406],"species":[407],"(ROS)":[408],"can":[409,603],"mediate":[411],"damage,":[413],"antioxidant":[418],"reagent":[419],"N-Acetylcysteine":[420],"(NAC),":[421],"helps":[423],"scavenging":[424],"ROS":[425,465,597],"replenishing":[427],"glutathione":[428],"stores,":[429],"indeed":[431],"capable":[432],"reducing":[434],"breaks":[438],"markers.":[442],"Since":[443],"cancer":[444],"particularly":[447],"oxidative":[450,510],"then":[453],"evaluated":[454],"anti-MM":[456],"activity":[457,496],"piperlongumine":[459],"(PL),":[460],"drug":[462],"accumulation.":[466],"PL":[473,486,498],"treatment,":[474],"PBMCs":[476],"minimally":[478],"affected.":[479],"As":[480],"expected,":[481],"apoptotic":[483],"effects":[484,547],"abrogated":[488],"upon":[489],"co-incubation":[490],"NAC,":[492],"indicating":[493],"on":[499],"ROS.":[500],"next":[502],"exploited":[503],"possibility":[505],"combining":[507],"cells,":[514],"hoping":[515],"overcome":[517],"threshold":[519],"tolerance":[521],"H929":[525],"OPM-2":[527],"transfected":[530],"or":[534,542],"treated":[535],"VE-821":[537],"DMSO":[541],"1-2.5":[543],"\u03bcM":[544],"PL;":[545],"synergic":[546],"Conclusion:":[565],"Replicative":[566],"patients,":[575],"who":[576],"disease,":[579],"hyperproliferation":[582],"poor":[584],"prognosis.":[585],"Strategies":[586],"aimed":[587],"shift":[589],"balance":[591],"towards":[592],"high":[593],"production":[598],"reduced":[600],"repair":[602],"decrease":[604],"benefit":[609],"otherwise":[612],"outcomes.":[614],"Disclosures":[615],"No":[616],"relevant":[617],"conflicts":[618],"interest":[620],"declare.":[622]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2017-01-26T00:00:00"}